The gap between claims that artificial intelligence will cure cancer and reality
In contrast to tech leaders' claims that artificial intelligence will defeat cancer, experts highlight the complex nature of the disease and the necessity of scientific processes.
While executives of major tech companies claim that artificial intelligence will cure cancer in the near future, clinicians and researchers emphasize that these claims do not reflect reality and that cancer is not a single disease.
Claims by Tech Leaders
Major tech executives are making bold statements that artificial intelligence will completely cure cancer over the next five to ten years or within a human lifetime.
The Approach of Scientists
Clinicians, oncologists, and researchers state that there is a distinct tension between the grand claims of tech circles and the meticulous, slow-moving reality of science.
The Complex Nature of Cancer
Sherene Loi, a medical oncologist at the Peter MacCallum Cancer Centre in Melbourne, states that a cure for all cancers within a decade is impossible until AI can conduct self-scalable experiments. Cancer is not a single disease, but rather encompasses over a hundred different types driven by genetic alterations.
Use of Artificial Intelligence Tools in Medicine
Today, artificial intelligence is considered a valuable supporting tool in drug development, treatment planning, the detection of early-stage suspicious conditions, and the removal of brain tumors.
Early Diagnosis and Treatment Studies
Ajit Goenka, a radiologist at the Mayo Clinic, emphasizes that AI can improve areas such as risk stratification, disease detection, and treatment selection, while using machine learning to examine microscopic changes in past computed tomography scans that went unnoticed.
Multidisciplinary Projects in Europe
The EUcanAI collaboration, led by neuropathologist Felix Sahm at Heidelberg University Hospital, is working to improve treatments for brain tumors and central nervous system cancers and to accelerate mutation analysis processes during surgery.
Key Obstacles Faced
Emilia Javorsky, a physician and scientist at the Future of Life Institute, points out that despite a 13-year movement in AI-assisted drug discovery, no drug has yet fully cleared FDA approval, reimbursement, and clinical adoption.